I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cost-Effectiveness Analysis of Tislelizumab Plus Chemothera..:
Zhou, Chongchong
;
Wei, Jingxuan
;
Xu, Kai
...
Risk Management and Healthcare Policy. 16 (2023) - p. 2447-2458 , 2023
Link:
https://doi.org/10.2147/rmhp.s436750
RT Journal T1 <Title>Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.2147_rmhp.s436750&Exemplar=1&LAN=DE A1 Zhou, Chongchong A1 Wei, Jingxuan A1 Xu, Kai A1 Lin, Yingtao A1 Zhang, Lingli A1 Li, Xin PB Informa UK Limited YR 2023 SN 1179-1594 JF Risk Management and Healthcare Policy VO 16 SP 2447 OP 2458 LK http://dx.doi.org/https://doi.org/10.2147/rmhp.s436750 DO https://doi.org/10.2147/rmhp.s436750 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
